Progress for chromophobe RCC at ASCO GU. Excited to check out the FOUR abstracts for #chRCC tomorrow (H31, H18, E21, E36) #chromophobe #GU25 @msaouel.bsky.social

Great start of the bladder oral abstract session at #GUASCO25 with CM274 follow up and NIAGRA follow up with @erplimackmd.bsky.social putting all into context of our current bladder MIBC approach but looking across the broader oncology data. Congrats to presenters

Wrote a blog for @kidney-cancer.bsky.social , all about being easier on yourself after a diagnosis. https://www.kidneycancer.org/stories/sid-sadler-grace/?fbclid=IwZXh0bgNhZW0CMTEAAR1I1CjuVcvCzKXMB18QUZyk5ziaQCIs_PYonHaHTAxVRu47npPunl64p4I_aem_tP5VV3aLQqMaGIZefk0b0g #Cansky #Oncsky #Medsky

Our paper in @nature.com is finally published: a prospective trial of a personalized Neoantigen Vaccine in Kidney Cancer www.nature.com/articles/s41... This is teamwork with @danafarber.bsky.social @yalecancer.bsky.social @harvardmed.bsky.social + Wu lab www.nature.com/articles/s41...

Hey! If you all over at #Cansky and #Oncsky haven’t already, please please follow my friend @katiekickscancer.bsky.social 🫶🏻 She’s a stage 4 kidney cancer survivor and thriver who has started her own non profit in the kidney cancer space and also just had a new book released😃 She’s the best 👏🏻

I’m worried about this year’s internal medicine match. Watching very talented IMG post docs struggle with the signaling system is disheartening. Wishing everyone the chance to find programs to give them a chance to grow, shine and receive the chance to enhance our medical village.

Happy to join the Bluesky community excited to see the medical community connecting